1.A Case of Delayed Administration of Naloxone for Morphine Intoxicated Patient.
Gun Bea KIM ; Won Nyung PARK ; Hong Du GU
Journal of The Korean Society of Clinical Toxicology 2012;10(1):33-36
Opioids are the one of the most commonly used drugs to control cancer pain all over the world. But, we should not overlook the potential risk of opioid intoxication because they have well-known detrimental side effects. The opioid intoxication can be diagnosed thorough various clinical manifestations. The altered mental status, respiratory depression, and miosis is very representative clinical features although these symptoms don't always appear together. Unfortunately the opioid-toxidrome can be varied. A 42 years old man came to our emergency room after taking about 900 mg morphine sulfate per oral. He was nearly alert and his respiration was normal. Even though his symptoms didn't deteriorated clinically, serial arterial blood gas analysis showed increase in PaCO2. So we decided to use intravenous naloxone. Soon, he was fully awaked and his pupils size was increased. After a continuous infusion of intravenous naloxone for 2 hours, PaCO2 decreased to normal range and his pupil size also returned to normal after 12 hours. Though the levels of serum amylase and lipase increased slightly, his pancreas was normal according to the abdominal computed tomography. He had nausea, vomit, and whole body itching after naloxone continuous infusion, but conservatively treated. We stopped the continuos infusion after 1 day because his laboratory results and physical examinations showed normal. As this case shows, it is very important to prescribe naloxone initially. If you suspect opioid intoxication, we recommend the initial use of naloxone even though a patient has atypical clinical features. In addition, we suggest intranasal administration of naloxone as safe and effective alternative and it's necessary to consider nalmefene that has a longer duration for opioid intoxication.
Administration, Intranasal
;
Amylases
;
Analgesics, Opioid
;
Blood Gas Analysis
;
Emergencies
;
Humans
;
Lipase
;
Miosis
;
Morphine
;
Naloxone
;
Naltrexone
;
Nausea
;
Pancreas
;
Physical Examination
;
Porphyrins
;
Pruritus
;
Pupil
;
Reference Values
;
Respiration
;
Respiratory Insufficiency
2.Combined Treatment of Photodynamic Therapy and Bevacizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration.
Hyun Woong KIM ; Jung Lim KIM ; Mi Hyun LEE ; Hyung Gon YOO ; In Young CHUNG ; Ji Eun LEE
Korean Journal of Ophthalmology 2011;25(4):231-237
PURPOSE: To evaluate the outcome of a combined photodynamic therapy and intravitreal injection of bevacizumab in choroidal neovascularization secondary to age-related macular degeneration. METHODS: Photodynamic therapy (PDT) was administered to 28 eyes followed by 3 consecutive bevacizumab injections. Patients were followed-up for more than 12 months. At baseline, 1, 3, 6, and 12 months post PDT, visual acuity (VA) and central macular thickness were measured using optical coherence tomography. RESULTS: The mean VA was significantly improved from logarithm of the minimal angle of resolution 0.86 at baseline to 0.69 at 1 month (p = 0.011), 0.63 at 3 months (p = 0.003), 0.64 at 6 months (p = 0.004) and 0.60 at 12 months (p < 0.001). Central macular thickness decreased significantly from 328.3 microm at baseline to 230.0 microm at 6 months and 229.9 microm at 1 year (p < 0.001). Reinjection mean number was 0.4 for 6 months and 0.8 for 12 months. By 1 year, retreatment was performed in 10 eyes (36%). CONCLUSIONS: PDT combined with three consecutive intraviteal bevacizumab injections was effective in improving VA and reducing central macular thickness.
Aged
;
Angiogenesis Inhibitors/*administration & dosage
;
Antibodies, Monoclonal, Humanized/*administration & dosage
;
Choroidal Neovascularization/diagnosis/*drug therapy/etiology
;
Dose-Response Relationship, Drug
;
Drug Therapy, Combination
;
Female
;
Fluorescein Angiography
;
Follow-Up Studies
;
Fundus Oculi
;
Humans
;
Intravitreal Injections
;
Macula Lutea/drug effects/*pathology
;
Macular Degeneration/*complications/diagnosis/drug therapy
;
Male
;
Photochemotherapy/*methods
;
Photosensitizing Agents/administration & dosage
;
Porphyrins/*administration & dosage
;
Retrospective Studies
;
Tomography, Optical Coherence
;
Treatment Outcome
;
Visual Acuity
3.Retinal Capillary Hemangioma Treated with Verteporfin Photodynamic Therapy and Intravitreal Triamcinolone Acetonide.
Shin Cho SUH ; Sun Young JIN ; Seon Hee BAE ; Chul Gu KIM ; Jong Woo KIM
Korean Journal of Ophthalmology 2007;21(3):178-184
PURPOSE: To report a case of retinal capillary hemangioma treated with verteporfin photodynamic therapy combined with intravitreal triamcinolone acetonide. METHODS: A 15-year-old female presented with metamorphopsia in the left eye for 7 days. Examination showed peripheral endophytic retinal capillary hemangioma, macular edema, and a best-corrected visual acuity of 20/50. The hemangioma and macular edema were treated with verteporfin photodynamic therapy and intravitreal triamcinolone acetonide. RESULTS: After 5 months of follow-up, involution of the hemangioma, reduction of macular edema, decrease of the feeder and draining vessel diameter, and improvement of best-corrected visual acuity to 20/25 was seen. CONCLUSIONS: This verteporfin photodynamic therapy combined with intravitreal triamcinolone acetonide appeared to cause involution of the hemangioma with reduction in macular edema and improvement in visual acuity.
Adolescent
;
Female
;
Fundus Oculi
;
Glucocorticoids/*administration & dosage/therapeutic use
;
Hemangioma, Capillary/diagnosis/*drug therapy
;
Humans
;
Injections
;
*Photochemotherapy
;
Photosensitizing Agents/*therapeutic use
;
Porphyrins/*therapeutic use
;
Retinal Neoplasms/diagnosis/*drug therapy
;
Tomography, Optical Coherence
;
Triamcinolone Acetonide/*administration & dosage/therapeutic use
;
Ultrasonography
;
Vitreous Body
4.Structural and Functional Outcomes in Chronic Central Serous Chorioretinopathy Treated with Photodynamic Therapy.
Pino CIDAD ; Eugenia GONZALEZ ; Monica ASENCIO ; Jesus GARCIA
Korean Journal of Ophthalmology 2015;29(5):331-335
PURPOSE: To study the retinal pigment epithelium (RPE) and retinal alterations in chronic central serous chorioretinopathy treated with photodynamic therapy, and its correlation with functional parameters such as best-corrected visual acuity (BCVA) and contrast sensitivity (CS). METHODS: Retrospective, noncomparative, consecutive evaluation by optical coherence tomography and its correlation with BCVA and CS in 31 eyes of 26 patients. RESULTS: In all affected patients, 88.5% were male with a mean age of 42.9 years. The right eye was involved in 64.5% of cases, bilateral in 19% and 73.9% were hyperopic (spherical refraction between 0 and +5.0 diopters). Of these cases, 51.5% had peri-RPE abnormalities, 17.3% hyperreflective substances at RPE, 19.4% RPE atrophy, 55.3% foveolar atrophy, 3.1% pigment epithelial detachment, 5.2% subretinal fluid persistence, 8.3% fibrin deposits, 68.4% photoreceptor inner and outer segment line interruption and 31.1% external limiting membrane interruption. CONCLUSIONS: Time evolution and number of outbreaks were related to the decrease in foveal and chorodial thickness and in those with worse BCVA and CS. RPE abnormalities and atrophy were related to the age of onset of symptoms. Photoreceptor elongation has been correlated with poor BCVA and inner and outer segment line destructuring and interruption with poor CS.
Adult
;
Central Serous Chorioretinopathy/diagnosis/*drug therapy/physiopathology
;
Chronic Disease
;
Female
;
Fluorescein Angiography
;
Follow-Up Studies
;
Fundus Oculi
;
Humans
;
Male
;
Middle Aged
;
Photochemotherapy/*methods
;
Photosensitizing Agents/administration & dosage
;
Porphyrins/*administration & dosage
;
Retina/*diagnostic imaging/drug effects/physiopathology
;
Retrospective Studies
;
Tomography, Optical Coherence
;
Treatment Outcome
;
*Visual Acuity